Almirall
Ester Guiu has a diverse work experience background. Ester started their career as an Investigador at Universitat Rovira i Virgili from 1999 to 2003. Ester then worked as a Post-doctoral Researcher at Technische Universiteit Eindhoven in 2004 and the Max Planck Institute of Molecular Physiology from 2004 to 2006. Ester then moved on to Farmaprojects as an R&D technical specialist from 2006 to 2009. Ester joined Polpharma as a Biopharmaceuticals Portfolio Manager from 2009 to 2011. Currently, they are working at Almirall, where they have held various roles including Director of Business & Launch Excellence and Director of Corporate Project Management Office, PMO.
Ester Guiu holds a Licenciatura in Ciencias Químicas from Universitat Rovira i Virgili. Ester later obtained a D.E.A. and a Doctora in Química orgánica y organometálica from the same university. In 2007-2009, Ester completed their MBA at Esade. Ester continued their education at Esade with the Advance Leadership Program in 2020 and the Almirall Digital Garden - Second Harvest program in 2021. In 2023, they completed the FLOW Leadership program (Almirall in company Executive Program) at Esade.
Almirall
11 followers
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents.